Rubrik, Inc.

RBRK · NYSE

$81.95▲ +2.07%

+$1.67 today

Mkt cap $16.87B
P/E 0.0
Day $80.43 – $83.95

Confidence

High conviction

The read

Rubrik beats EPS estimates with $0.16 vs -$0.03, shares modestly up post-earnings

Rubrik reported Q2 EPS of $0.16, significantly beating the $-0.03 estimate, reflecting strong operational execution. The stock traded slightly higher post-earnings, supported by solid revenue growth and positive analyst sentiment despite high valuation and weak margins. Investors should monitor next-quarter revenue and ARR updates for growth sustainability and margin improvement.

Confidence note: High confidence due to clear EPS beat, strong growth metrics, and detailed analyst consensus; valuation and margin risks remain.

What happened

Earnings print

Rubrik reported EPS of $0.16 versus an estimate of -$0.03, a 668% positive surprise.

Guidance

No explicit guidance was provided, but analyst consensus remains bullish with a $92.08 average target price.

Price reaction

Shares rose modestly by 0.18% on the day following the earnings release, indicating cautious optimism.

Street narrative

The earnings beat was driven by strong revenue and ARR growth, though operating margins remain weak at -21.4%. Valuation remains elevated with a forward P/E of 112.3, reflecting high growth expectations.

So what

What changed

EPS beat estimates by $0.19, with reported EPS at $0.16 versus -$0.03 expected.

What the market is pricing

The modest share price increase post-earnings reflects cautious optimism amid high valuation and margin concerns.

Fundamental takeaway

Maintain a constructive bias; watch next-quarter revenue and ARR for growth and margin trajectory confirmation.

Next 30–90 days

Bull

50%

Sustained revenue and ARR growth combined with margin improvement drives multiple expansion and share appreciation.

Next-quarter revenue growth exceeding 40% YoY
ARR growth acceleration

Base

34%

Growth remains solid but margins stay pressured, leading to sideways stock performance with limited multiple expansion.

Revenue growth around 30-40% YoY
Stable ARR growth

Bear

16%

Growth decelerates sharply and margins worsen, triggering valuation contraction and share price decline.

Revenue growth below 20% YoY
ARR growth contraction

What to do

If you hold it

Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.

If you're watching

Add only if next-quarter guidance is reiterated or raised; avoid if guidance is cut or geopolitical risk escalates.

Keep on your radar

Next-quarter revenue growth rate (due Q3 2026)
ARR growth trajectory (next 90 days)
Operating margin trends (next quarterly report)
Analyst target price revisions